New Drugs for Malignancy, An Issue of Hematology/Oncology Clinics of North America
Topics include: Targeting IGF-1R, Tyrosine Kinase Inhibitors in Lung Cancer, Targeting mTOR, Targeting Hedgehog, Mitotic Inhibitors, Topoisomerase I Inhibitors , and New Strategies and Drugs Inhibiting Folate Pathways.
Leider schon ausverkauft
143.99 €
versandkostenfrei
Produktdetails
Produktinformationen zu „New Drugs for Malignancy, An Issue of Hematology/Oncology Clinics of North America “
Weitere Produktinformationen zu „New Drugs for Malignancy, An Issue of Hematology/Oncology Clinics of North America “
Topics include: Targeting IGF-1R, Tyrosine Kinase Inhibitors in Lung Cancer, Targeting mTOR, Targeting Hedgehog, Mitotic Inhibitors, Topoisomerase I Inhibitors , and New Strategies and Drugs Inhibiting Folate Pathways.
Bibliographische Angaben
- Autor: Franco Muggia
- Verlag: ELSEVIER HEALTH SCIENCE
- EAN: 9781455738762
Kommentar zu "New Drugs for Malignancy, An Issue of Hematology/Oncology Clinics of North America"
0 Gebrauchte Artikel zu „New Drugs for Malignancy, An Issue of Hematology/Oncology Clinics of North America“
Zustand | Preis | Porto | Zahlung | Verkäufer | Rating |
---|
Schreiben Sie einen Kommentar zu "New Drugs for Malignancy, An Issue of Hematology/Oncology Clinics of North America".
Kommentar verfassen